Fermosa Bio Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.65 Cr
as on 15-12-2024
About Fermosa Bio
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.65 Cr.
Shamrao Dhannure, Mahammadhasan Momin, Piyush Modi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC373976
- Company No.
373976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Fermosa Bio?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishith Zatakia  | Director | 27-Dec-2021 | Current |
| Shamrao Dhannure | Director | 27-Dec-2021 | Current |
| Mahammadhasan Momin | Director | 10-Jan-2024 | Current |
| Piyush Modi | Director | 27-Dec-2021 | Current |
| Hardik Dani | Director | 27-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Fermosa Bio.
Fermosa Bio Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Fermosa Bio?
Unlock access to Fermosa Bio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kalpasthana Life Care Products Private LimitedActive 9 years 4 months
Shamrao Dhannure is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2024 | ₹2.50 Cr | Open |
Others Creation Date: 30 Mar 2024 | ₹1.50 M | Open |
How Many Employees Work at Fermosa Bio?
Fermosa Bio has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fermosa Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fermosa Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
